Roger A Barker
University of Cambridge
H-index: 127
Europe-United Kingdom
Top articles of Roger A Barker
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson’s Disease: The International Linked Clinical Trials initiative | Richard K Wyse Tom Isaacs Roger A Barker Mark R Cookson Ted M Dawson | 2024/4/5 | |
The basal forebrain cholinergic system as target for cell replacement therapy in Parkinson’s disease | Anders Björklund Roger A Barker | 2024/1/27 | |
Noradrenergic modulation of saccades in Parkinson’s disease | medRxiv | Isabella F Orlando Frank H Hezemans Rong Ye Alexander G Murley Negin Holland | 2024/1/5 |
Sleep disturbances are associated with accelerated postural instability and death in Parkinson’s disease | Parkinsonism & Related Disorders | SA Griti M Camacho R Barker D Breen | 2024/5/1 |
Plasma GFAP and its association with disease severity in Huntington’s disease | Journal of Neurology | Kübra Tan Melanie Alpaugh Nicholas J Ashton Sylvain Chouinard Roger A Barker | 2024/4 |
The immunological profile of RC17 hESC-derived dopaminergic neural progenitor cells in vitro: implications for the STEM-PD clinical trial. | bioRxiv | Annabel J Curle Shaline V Fazal Shamma Qarin Sarah K Howlett Xiaoling He | 2024 |
Chromatin accessibility during human first-trimester neurodevelopment | Nature | Camiel CA Mannens Lijuan Hu Peter Lönnerberg Marijn Schipper Caleb C Reagor | 2024/5/1 |
Genetic risk of Parkinson disease and progression | Neurology Genetics | Hirotaka Iwaki Cornelis Blauwendraat Hampton L Leonard Ganqiang Liu Jodi Maple-Grødem | 2024/3/20 |
Generation of human cerebral organoids with a structured outer subventricular zone | Cell Reports | Ryan M Walsh Raffaele Luongo Elisa Giacomelli Gabriele Ciceri Chelsea Rittenhouse | 2024/4/23 |
A decade of progress: Achievements and future challenges for regenerative medicine research in the United Kingdom | Annabel J Curle Josephine L Barnes Robert Owen Roger A Barker Alicia El Haj | 2024/3/11 | |
PET Ligands for Imaging Mutant Huntingtin Aggregates: A Case Study in Non-For-Profit Scientific Management | Catherine Dickmann S Milicevic Sephton RA Barker FI Aigbirhio | 2024/4/8 | |
Sham surgery for the trialing of cell-based therapies to the CNS may not be necessary | Cell Stem Cell | Viviane Tabar Roger A Barker | 2024/2/1 |
A human prenatal skin cell atlas reveals immune cell regulation of skin morphogenesis | bioRxiv | Nusayhah Hudaa Gopee Ni Huang Bayanne Olabi Chloe Admane Rachel A Botting | 2023 |
Challenges in the clinical advancement of cell therapies for Parkinson’s disease | Sophie Skidmore Roger A Barker | 2023/4 | |
A spatial human thymus cell atlas mapped to a continuous tissue axis | bioRxiv | Nadav Yayon Veronika R Kedlian Lena Boehme Chenqu Suo Brianna Wachter | 2023/10/27 |
Selective neurodegeneration generated by intravenous α‐synuclein pre‐formed fibril administration is not associated with endogenous α‐synuclein levels in the rat brain | Brain Pathology | Wei‐Li Kuan Maha Alfaidi Catherine B Horne Benjamin Vallin Sarah Fox | 2023/5 |
Dynamics of chromatin accessibility during human first-trimester neurodevelopment | bioRxiv | Camiel CA Mannens Lijuan Hu Peter Lönnerberg Marijn Schipper Caleb Reagor | 2023/8/20 |
BRAIN COMMUNICATIONS | Hanna Leister Felix F Krause Beatriz Gil Ruslan Prus Inna Prus | 2024 | |
Detection of antibodies against the huntingtin protein in human plasma | Cellular and Molecular Life Sciences | Hélèna L Denis Melanie Alpaugh Claudia P Alvarez Alexis Fenyi Roger A Barker | 2023/2 |
Clinical trial protocol: TRANSCEND 1–an observational study of patients with moderate Parkinson’s disease (P2-11.002) | Paul-Visse Gesine Håkan Widner Regine Bergholdt Helle Frimer-Larsen Ida Stenfeldt Mathiasen | 2023/4/25 |
